Overview
Ondansetron is a selective serotonin 5-HT3 receptor antagonist developed in the 1980s by GlaxoSmithKline. It revolutionized the management of chemotherapy-induced nausea and vomiting (CINV) and is now widely used in oncology and surgical settings. The drug is listed on the WHO Model List of Essential Medicines. As a first-generation 5-HT3 antagonist, ondansetron demonstrates high affinity for serotonin receptors in the gut and central nervous system. Its development marked a significant improvement over older antiemetics, offering better efficacy with fewer side effects like sedation or extrapyramidal symptoms.
Physical and Chemical Properties
Ondansetron appears as a white to off-white crystalline powder with good stability under recommended storage conditions. The compound shows moderate solubility in water (about 10 mg/mL) and ethanol, which facilitates formulation into various dosage forms including tablets, oral solutions, and injectables. The molecule contains a carbazole moiety and an imidazole ring, contributing to its receptor binding characteristics. Its melting point of 231-233°C indicates relatively high thermal stability. The pKa values of 7.4 and 8.9 reflect its weak basic nature, influencing its pharmacokinetic behavior.
Main Applications
The primary use of ondansetron is in preventing and treating nausea and vomiting associated with cancer chemotherapy, especially highly emetogenic regimens containing cisplatin or cyclophosphamide. It's equally effective for radiation-induced nausea and postoperative nausea and vomiting (PONV). In clinical practice, ondansetron is often administered as a single IV dose before chemotherapy or as oral tablets for continued prophylaxis. Off-label uses include management of hyperemesis gravidarum and gastroenteritis in some cases, though these applications require careful risk-benefit assessment.
Safety and Storage
Ondansetron is generally well-tolerated but may cause mild side effects like headache (11-27% incidence), constipation (2-11%), or dizziness. Serious but rare adverse effects include QT interval prolongation, particularly with IV administration in patients with electrolyte abnormalities. Proper storage requires protection from light and moisture at controlled room temperature (15-25°C). Bulk pharmaceutical material should be kept in tightly sealed containers with desiccants. Stability studies indicate the powder remains chemically stable for at least 24 months when stored correctly.
B2B Procurement Guide
When procuring ondansetron in bulk, pharmaceutical buyers should prioritize suppliers with cGMP certification and proper documentation including Certificate of Analysis (CoA), DMF references, and stability data. Key specifications to verify include purity (≥98%), residual solvents (meeting ICH guidelines), and particle size for formulation purposes. Market prices fluctuate based on API source, with Indian and Chinese manufacturers typically offering competitive rates. However, buyers should balance cost considerations with quality assurance, particularly for injectable-grade material. Minimum order quantities usually range from 1-10 kg for standard transactions.
Related Manufacturers
- 主营：恩丹西酮工业级、分析纯试剂
- 主营：正己醇、福淋酚、十二烷酸、恩丹西酮分析纯、氨基甲醛、正十一烷、化学试剂、氧化苄基、月桂氮酮、2-乙基己醇、丙烷二羧酸、辛癸混合酸、肌醇六磷酸分析
- 主营：硫代癸烷、化学试剂、总镍试剂、恩丹西酮、棕榈酸甲酯、正辛酸甲酯、仲丁基氯化镁、正庚基溴化镁、仲丁基溴化镁、棕榈酸异丙酯
- 主营：硫酸汞、硝酸汞、雷尼镍、恩丹西酮生产厂家、二十烷、丁二酸、硫化银、正己醇、硫酸镉、铋酸钠、苯甲醇、硅酸钠、正辛酸、硫酸镁、磷钨酸、滑石粉、草酸锡、蓖麻油、椰子油、钒试剂、异辛醇
- 主营：1-苯丙醇、1-萘甲醚、科隆试剂、罗恩试剂、金刚烷醇、1-溴十八烷、2-恶唑烷酮、1-甲酰哌啶、2-氟苯甲醛、2-甲基吡嗪、2-氮己环酮、1-溴金刚烷、阿拉丁试剂、麦克林试剂、科密欧试剂、大小化工试剂
- 主营：对照品、科研实验、试剂盒、恩丹西酮、多糖、安石榴苷、儿茶素、绿原酸、尿石素、人参皂苷、花青素、维生素、异鼠李素、甘草系列、人参系列、补骨脂系列、雷公藤系列、黄芩系列、柴胡系列、丹参系列、酸枣仁系列、重楼系列、大黄系列、五味子系列、化合物、黄芪皂苷系列
- 主营：科研试剂、n-甲基吡咯烷酮
- 主营：恩丹西酮价格、大小化工试剂
- 主营：水杨甙、吡喃灵、乙酸镍、盐酸恩丹西酮146475、酸性橙、硫酸锑、硫酸锂、二乙烯、硫酸锰、075-68-6)、甲醇钙、酸性紫、羟钴胺、敌螨普、磷酸铵、硫化褐、丙酸铵、中性红、碳酸镍、赖氨酸、柚皮素、乙氧基、氟苯基、酸性红、羟乙基、白碳黑